成人小说亚洲一区二区三区,亚洲国产精品一区二区三区,国产精品成人精品久久久,久久综合一区二区三区,精品无码av一区二区,国产一级a毛一级a看免费视频,欧洲uv免费在线区一二区,亚洲国产欧美中日韩成人综合视频,国产熟女一区二区三区五月婷小说,亚洲一区波多野结衣在线

立即打開
仿制藥真的能媲美專利藥嗎?(節(jié)選)

仿制藥真的能媲美專利藥嗎?(節(jié)選)

Katherine Eban 2013-01-15
消費者經(jīng)常被告知仿制藥和專利藥一模一樣。不過,越來越多的醫(yī)學(xué)專家指出,兩者存在差別。這種差別不僅體現(xiàn)在有效成分的濃度上,同時也體現(xiàn)在輔料的選用以及由此導(dǎo)致的人體對藥物的吸收程度。

????去年10月,美國食品和藥物管理局(Food and Drug Administration,簡稱FDA)做出了一項極不尋常的舉動:宣布該機構(gòu)此前已批準(zhǔn)的一種仿制藥——廣泛應(yīng)用的抗抑郁癥劑安非他酮的仿制品——與專利藥在“生物等效性”上并不相同。FDA決定撤銷批準(zhǔn)。

????監(jiān)管機構(gòu)的舉動震動了市場。負(fù)責(zé)銷售該藥的梯瓦制藥公司(Teva Pharmaceuticals)決定立即停止銷售,其它公司也在FDA的要求下對旗下的安非他酮仿制藥進行試驗。許多醫(yī)生和醫(yī)學(xué)會一直在私下探索一個近乎異端的問題:仿制藥真的與專利品牌藥一模一樣嗎?而他們表示,在相當(dāng)多的情況下,答案都是否定的。FDA此次出手,更是為他們的行為注入了新的動力。

????如果你是外行,你也許這么看仿制藥:他們和專利藥完全一致,只是包裝不同。仿制藥廠商之所以能以極其低廉的價格出售藥品,是因為他們沒有巨額的藥品研發(fā)和市場推廣費用。

????所以,這就解釋了為什么美國醫(yī)藥界在2012年開出的處方中,超過80%的都是仿制藥。根據(jù)美國仿制藥協(xié)會(Generic Pharmaceutical Association)的數(shù)據(jù),無品牌的仿制藥去年一共為美國人民節(jié)省了1,930億美元醫(yī)藥費。

????不過,仿制藥和專利藥的差別可比你想像的要大得多。首先,專利藥廠商在專利過期、或者遭到質(zhì)疑時,并不會將其制造方法拱手讓出。專利只列出了藥品成分,并沒有詳細解釋制造藥品的過程。事實上,制造仿制藥通常需要逆向工程,得出的結(jié)果絕非專利藥的復(fù)制品,僅僅只是其近似值。

????FDA的相關(guān)規(guī)定也明確承認(rèn)這點。它的“生物等效性”的界定范圍大得有些讓人驚訝:仿制藥的有效成分在人體血液內(nèi)的最高濃度必須不低于專利藥的20%并且不高于25%。這意味著那些標(biāo)榜著“原汁原味”的仿制藥,其有效成分與專利藥的差別可能高達45%。

????仿制藥與專利藥還存在其它差別。雖然仿制藥必須含有與專利藥一致的有效成分,但其其它成分,也就是通常所說的輔料,可以不同。事實上,這些輔料的品質(zhì)通常要低于專利藥。這樣的差別會影響到“生物利用率”——人體血液系統(tǒng)所能夠吸收的藥品數(shù)量。美國心臟協(xié)會(American Heart Association)最近指出,“一些通常被認(rèn)為可有可無的輔料,如酒精糖、環(huán)糊糖和聚山梨醇酯八十等,可能會改變藥物溶解率,從而影響到其生物利用率。”

????譯者:項航

????In October the Food and Drug Administration took a highly unusual step: It declared that a generic drug it had previously approved -- a version of the popular antidepressant Wellbutrin -- was not in fact "bioequivalent" to the name-brand version. The FDA withdrew its approval.

????The federal action shook the business. Teva Pharmaceuticals (TEVA), which marketed the generic in question, has stopped selling it, and other companies are now testing their versions of Wellbutrin at the FDA's request. The episode is bringing momentum to a movement that has been quietly building among many doctors and medical societies that are increasingly willing to ask a question that borders on heresy: Are generics really identical to the branded products they are meant to replicate? To a surprising degree, they say, the answer is no.

????If you're a layperson, this is the way you probably think of generics: They're the exact same products in different packaging; generics companies can sell such medications for a fraction of the cost of the originals because they don't have to spend huge sums on drug development and marketing.

????That apparent miracle explains why more than 80% of all U.S. prescriptions dispensed in 2012 were generic. Using nonbranded medications saved Americans $193 billion this past year, according to the Generic Pharmaceutical Association.

????But generic drugs diverge from the originals far more than most of us believe. For starters, it's not as if the maker of the original pharmaceutical hands over its manufacturing blueprint when its patent runs out or is challenged. The patent reveals the components, but it doesn't explain how to make the drug. In reality, manufacturing a generic requires reverse engineering, and the result is an approximation rather than a duplicate of the original.

????The FDA's rules effectively acknowledge that. The agency's definition of bioequivalence is surprisingly broad: A generic's maximum concentration of active ingredient in the blood must not fall more than 20% below or 25% above that of the brand name. This means a potential range of 45%, by that measure, among generics labeled as being the same.

????There are other differences. The generic must contain the same active ingredient as the original. But the additional ingredients, known as excipients, can be different and are often of lower quality. Those differences can affect what's called bioavailability -- the amount of drug that could potentially be absorbed into the bloodstream. As the American Heart Association recently noted, "Some additives traditionally thought to be inert, such as alcohol sugars, cyclodextrans, and polysorbate-80, may alter a drug's dissolution, thereby impacting its bioavailability."

掃描二維碼下載財富APP
人人妻人人爽人人做夜欢视频九色| 久久久久久国产精品免费无码| 久久精品无码一区二区日韩AV| 欧洲美熟女乱又伦| 女同ⅹxx女同les高潮视频| 国产乱人伦精品免费| 99久久精品免费看国产一区二区| 国产精品无码亚洲字幕资不卡| 亚洲中文有码字幕日本第一页| 中文字幕在线人成视频| 精品无码一区在线观看| 2020国产精品视频免费| 夜夜天天狠狠偷偷青青久久| 久久婷婷五月综合丁香人人爽| 国产日韩欧美视频成人| 亚洲AV秘无码一区二区三资讯,| 两性午夜福利国产一级毛片| 无人区码一码二码三码区别新月| 亚洲AV无码乱观看明星换脸VA| 精品无码人妻一区二区三| 久久AV无码精品人妻出轨| 亚洲爆乳成av人在线视菜奈实| 成人区人妻精品一区二区不卡网站| 国产在线观看你懂的网址视频| 曰批全过程免费视频观看软件下载| 亚洲精中文字幕无码专区| 少妇高潮喷水惨叫久无码| 亚洲欧美日韩国产成人一区| 夫目前侵犯一区二区三区| 亚洲日产乱码一二三区别| 在线免费播放一级毛片| 不卡高清无码精品免费在线观| 天天干天天射天天操| 中文字幕一区二区三区精华液| 少妇无码AV无码一区| 国产成人无码a区视频在线观看| 国产日韩在线视频| 国产在线精品一区二区夜色| 亚洲精品国产原创电影在线| 真人无码一区二区三区| 一本色道无码不卡在线观看|